Azoury Saïd C, Shammas Ronnie L, Othman Sammy, Sergesketter Amanda, Brigman Brian E, Nguyen Jie C, Arkader Alexandre, Weber Kristy L, Erdmann Detlev, Levin L Scott, Kovach Stephen J, Innocenti Marco
From the Division of Plastic Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center.
Division of Plastic, Maxillofacial, and Oral Surgery, Department of Surgery.
Plast Reconstr Surg. 2023 Apr 1;151(4):805-813. doi: 10.1097/PRS.0000000000010001. Epub 2022 Dec 6.
Vascularized fibula epiphyseal flap was first described in 1998 for proximal humeral reconstruction in children/infants. The authors aim to review their international, multi-institutional, long-term outcomes.
An international, multi-institutional review (2004 to 2020) was conducted of patients younger than 18 years undergoing free vascularized fibula epiphyseal transfer for proximal humeral reconstruction. Donor- and recipient-site complications, pain, and final ambulatory status were reviewed. Growth of the transferred bone was assessed under the guidance of a pediatric musculoskeletal radiologist.
Twenty-seven patients were included with a median age of 7 years (range, 2 to 13 years). Average follow-up was 120 ± 87.4 months. There were two flap failures (7.4%). Recipient-site complications included fracture [ n = 11 (40.7%)], avascular necrosis of the fibula head [ n = 1 (3.7%)], fibular head avulsion [ n = 1 (3.7%)], infection [ n = 1 (3.7%)], and hardware failure [ n = 1 (3.7%)]. Operative fixation was necessary in one patient with a fracture. The case of infection necessitated fibula explantation 2 years postoperatively, and ultimately, prosthetic reconstruction. Sixteen patients developed peroneal nerve palsy (59.3%): 13 of these cases resolved within 1 year (81% recovery), and three were permanent (11.1%). One patient (3.7%) complained of upper extremity pain. Longitudinal growth was confirmed in all but three cases [ n = 24 (88.9%)] at an average rate of 0.83 ± 0.25 cm/year.
The vascularized fibula epiphysis for proximal humerus reconstruction in children preserves the potential for future growth and an articular surface for motion. Peroneal nerve palsy is common following harvest, although this is often transient. Future efforts should be geared toward reducing postoperative morbidity.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
带血管蒂腓骨骨骺瓣于1998年首次被描述用于儿童/婴幼儿肱骨近端重建。作者旨在回顾其国际多机构长期疗效。
对2004年至2020年间18岁以下接受游离带血管蒂腓骨骨骺转移进行肱骨近端重建的患者进行了一项国际多机构回顾研究。对供区和受区并发症、疼痛及最终的行走状态进行了评估。在儿科肌肉骨骼放射科医生的指导下评估移植骨的生长情况。
纳入27例患者,中位年龄7岁(范围2至13岁)。平均随访时间为120±87.4个月。有2例皮瓣失败(7.4%)。受区并发症包括骨折[n = 11(40.7%)]、腓骨头缺血性坏死[n = 1(3.7%)]、腓骨头撕脱[n = 1(3.7%)]、感染[n = 1(3.7%)]和内固定失败[n = 1(3.7%)]。1例骨折患者需要手术固定。感染病例术后2年需要取出腓骨,最终进行假体重建。16例患者出现腓总神经麻痹(59.3%):其中13例在1年内恢复(恢复率81%),3例为永久性(11.1%)。1例患者(3.7%)抱怨上肢疼痛。除3例病例外,其余所有病例均证实有纵向生长[n = 24(88.9%)],平均生长速度为0.83±0.25厘米/年。
用于儿童肱骨近端重建的带血管蒂腓骨骨骺保留了未来生长的潜力和运动的关节面。取骨后腓总神经麻痹很常见,尽管通常是短暂的。未来应致力于降低术后发病率。
临床问题/证据级别:治疗性,IV级。